As president, Brooks will be responsible for setting Biosense Webster’s global strategy and advancing its innovation agenda to position the company for continued growth.
Brooks succeeds Michael Bodner, who is now the global head of heart recovery for J&J MedTech. She has more than 25 years of experience in the cardiovascular field with a primary focus on electrophysiology.
Most recently, Brooks was the VP of global strategic marketing at Biosense Webster, where she worked with cross-functional and international teams to set the strategy and shape the company product pipeline to drive growth, market share and profitability. She previously joined the company in 2014 and has held numerous roles within the global strategic marketing organization at Biosense Webster.
“Jass Brooks is a well-respected, collaborative leader with a deep knowledge of the electrophysiology space, a track record of successfully driving growth and market leadership, as well as a deep commitment to developing talent and fostering a culture of collaboration and inclusivity,” said Celine Martin, company group chair of cardiovascular and specialty solutions. “Jass has dedicated her career to championing excellence in patient outcomes and solving unmet medical needs, and she will continue to harness this passion in leading Biosense Webster as the company advances innovation solutions to help people with AFib live the lives they want.”
Prior to joining Biosense Webster, Brooks held numerous leadership roles at GE Healthcare in marketing, global strategic marketing, product development and engineering.
“It is an honor to lead Biosense Webster, with its proud legacy and unmatched capabilities in cardiac catheter ablation,” said Brooks. “I look forward to continuing to partner closely with the electrophysiology community to elevate standards of care in AFib.”
